ONO-4578-07 relative bioavailability and food effect study
Completed
- Conditions
- Solid Cancer
- Registration Number
- jRCT2071210056
- Lead Sponsor
- Ono Pharmaceutical Co.,LTD
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Male
- Target Recruitment
- 15
Inclusion Criteria
Japanese healthy adult male, >=20 and <=40 of age, >=18.5 and <25.0 of BMI
Exclusion Criteria
Medical history of severe disease, severe allergy for foods and drugs
Study & Design
- Study Type
- Interventional
- Study Design
- crossover assignment
- Primary Outcome Measures
Name Time Method - relative bioavailability , food effect on ONO-4578
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What is the molecular mechanism of ONO-4578-07 in targeting solid cancers?
How does ONO-4578-07 compare to standard-of-care treatments for solid tumors in terms of efficacy and safety?
Are there specific biomarkers associated with the effectiveness of ONO-4578-07 in solid cancer patients?
What are the potential adverse events linked to ONO-4578-07 and how can they be managed?
What related compounds or combination therapies is Ono Pharmaceutical Co., LTD developing alongside ONO-4578-07 for solid cancers?